Drugs / JWK006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06300476 | Nov 2023 → Dec 2026 expected | Stargardt disease | West China Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWK006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06300476 ↗ |
| Route | Other | “Subretinal administration of gene therapy vector JWK006 to one eye.” NCT06300476 ↗ |
| Target | ABCA4 | “JWK006 is packed by adeno-associated virus vector that expressing ABCA4 gene.” NCT06300476 ↗ |